Stockreport

iCAD Highlights Promising Clinical Data Demonstrating Ability to Reduce Breast Interval Cancer Rates and Decrease Recall Rates at ECR 2024; Showcases Additional Platform Offerings

icad inc.  (ICAD) 
Last icad inc. earnings: 2/27 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: icadmed.com/financial-news-and-events.html
PDF Clinical evidence demonstrates ProFound Detection’s AI may help reduce breast interval cancer (IC) rates and decrease recall rates without additional false negatives Fin [Read more]